Search Results - "Qureshi, Parisa"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
  2. 2

    MPN-070 Real-World Clinical Outcomes in Patients With Myelofibrosis (MF) Previously Treated With Ruxolitinib (RUX) by Jain, Tania, Katzen, Harvey, Zeng, Jia, Nguyen, Hiep, Aton, Lindsay, Qureshi, Parisa, Fares, Marielle, Shih, Yu-Hsuan, Tang, Derek, Vergara, Sara, DeGutis, Irene S., Gerds, Aaron T.

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…Fedratinib (FEDR) and pacritinib (PAC) were approved by the FDA in August 2019 and February 2022, respectively, for treatment of intermediate- and high-risk…”
    Get full text
    Journal Article